Distribution and clinicopathological characteristics of G-CSF expression in tumor cells and stromal cells in upper tract urothelial carcinoma
2025

G-CSF Expression in Upper Tract Urothelial Carcinoma

Sample size: 112 publication 10 minutes Evidence: high

Author Information

Author(s): Kobayashi Go, Sekino Yohei, Nakahara Hikaru, Kobatake Kohei, Goto Keisuke, Hayashi Tetsutaro, Sentani Kazuhiro, Hinata Nobuyuki

Primary Institution: Hiroshima University

Hypothesis

The study aims to clarify the clinicopathological significance of G-CSF expression in upper tract urothelial carcinoma (UTUC).

Conclusion

G-CSF expression in tumor and stromal cells is associated with poor prognosis in UTUC, suggesting its potential as a prognostic marker.

Supporting Evidence

  • G-CSF expression was significantly higher in tumor tissues compared to normal urothelium.
  • G-CSF expression in stromal cells was associated with poor prognosis.
  • Stromal G-CSF expression was an independent prognostic factor.
  • High G-CSF expression correlated with advanced tumor stage and high grade.
  • Patients with G-CSF positive stromal cells had significantly lower cancer-specific survival.

Takeaway

This study found that a protein called G-CSF is more common in cancer cells of the urinary tract and can help doctors predict how serious the cancer might be.

Methodology

The study analyzed G-CSF expression in 112 UTUC samples using immunohistochemistry.

Potential Biases

Potential bias due to the retrospective nature of the study.

Limitations

The study is retrospective and may have bias due to patient selection; further research with a larger population is needed.

Participant Demographics

Mean age of participants was 71.4 years, with 73% being male.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1007/s00432-024-06045-1

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication